Atlantic Peptides Now Offers Glucagon, a 29-Chain Amino Acid, to Scientific Research Laboratories and Academia Institutions for Research Pertaining to Diabetes Treatment
Atlantic Peptides, a custom peptide synthesizer based out of Lewisburg, announces that it will now offer the 29-chain amino acid, Glucagon, to scientific research laboratories and academia institutions for research pertaining to the treatment and therapy of diabetes.
Atlantic Peptides (http://www.atlanticpeptides.com/), a custom peptide manufacturer that works with scientific research laboratories and academic institutions from around the world, announces that it will now offer Glucagon as one of its amino acid peptides. The hormones contained in the 29-chain amino acid counter the regulatory functions of insulin, and have been aggressively researched throughout the decade as a potential treatment of diabetes.
Glucagon is manufactured in the pancreas of both animals and humans, and has the ability to increase low levels of blood sugar, thereby increasing one’s blood glucose concentration for the treatment of hypoglycemia – a life threatening condition that may render a victim unconscious if lacking the appropriate amounts of glucose in the bloodstream. In addition, the peptide hormone triggers the liver to convert stored glycogen into glucose, which may then act even further to signal the body to release insulin.
Although it may be effective in this nature, it also may play a danger in producing toxic fibrils, which is why the peptide has been researched quite extensively throughout the years.
“More than 25 million Americans have diabetes,” said Jon Hanson, “which is why Atlantic Peptides is now offering the peptide to our researchers. We’ve had an influx of requests for the peptide, because the medical industries are looking to find a solution, or at least a form of therapy, to help alleviate the health consequences of this life threatening disease.”
Atlantic Peptides offers an array of custom and catalog peptides to the research industries, and also manufacturers polyclonal and monoclonal antibodies. It also works closely with the pharmaceutical industry, by supplying peptides for those conducting pre-GMP studies through cGMP manufacture.
The Lewisburg facility also offers competitive prices with online quotes, and its analytical instruments are checked and calibrated weekly to ensure the accurate production of antibodies and development of assay(s).
For more information about Atlantic Peptides, visit www.atlanticpeptides.com.
About Atlantic Peptides
Atlantic Peptides manufactures synthetic peptides, as well as provides mono- and poly-clonal antibodies to the academic and life-science industries across the world. Atlantic Peptides also offers personalized, custom services to address individual business needs, and also works with pharmaceutical industries for research studies.